M&A Deal Summary

IZI Medical Acquires RadioMed

On December 17, 2019, IZI Medical acquired medical products company RadioMed from IBA

Acquisition Highlights
  • This is IZI Medical’s 4th transaction in the Medical Products sector.
  • This is IZI Medical’s 4th transaction in the United States.
  • This is IZI Medical’s 1st transaction in Tennessee.

M&A Deal Summary
Date 2019-12-17
Target RadioMed
Sector Medical Products
Buyer(s) IZI Medical
Sellers(s) IBA
Deal Type Divestiture

Target

RadioMed

Bartlett, Tennessee, United States
RadioMed Corp. is an implantable fiducial marker used for soft tissue tumor localization for enhanced accuracy in radiation therapy planning and delivery. RadioMed Corp. was established in 1997 and is based in Bartlett, Tennessee.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

IZI Medical

Owings Mills, Maryland, United States
Category Company
Founded 1991
Sector Medical Products
Revenue 30M GBP (2022)
DESCRIPTION

IZI Medical is a developer, manufacturer, and provider of medical consumable accessories used in radiology, radiation therapy, vertebroplasty, and image-guided surgery procedures. IZI has built a diverse portfolio of products backed by strong intellectual property and currently sells to more than 1,000 domestic customers as well as internationally across 25 countries. IZI Medical was formed in 1991 and is based in Owings Mills, Maryland.

DEAL STATS #
Overall 4 of 4
Sector (Medical Products) 4 of 4
Type (Divestiture) 4 of 4
State (Tennessee) 1 of 1
Country (United States) 4 of 4
Year (2019) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-01-08 Cook Medical - Quick-Core Biopsy & Breast Localization Needle Assets

Bloomington, Indiana, United States

Cook Medical, Inc. - Quick-Core Biopsy & Breast Localization Needle Assets are commercially marketed under the highly regarded Quick-Core® Biopsy Needle, MReye® Breast Localization Coil, and the Kopans and X-Reidy Lesion Localization Needles.

Buy -

Seller(S) 1

SELLER

IBA

Louvain-La-Neuve, Belgium
Category Company
Founded 1986
Sector Medical Products
Employees1,943
Revenue 429M EUR (2023)
DESCRIPTION

IBA we dare to develop innovative solutions pushing back the limits of science. We share ideas and know-how with our customers, our partners and leading experts to bring new solutions for the diagnosis and treatment of cancer and for the benefits of patients. We care of the well-being of patients and stakeholders as it is together that we complete our mission to Protect Enhance and Saves lives. IBA was founded in 1986 and is based in Louvain-La-Neuve, Belgium.

DEAL STATS #
Overall 3 of 3
Sector (Medical Products) 2 of 2
Type (Divestiture) 2 of 2
State (Tennessee) 1 of 1
Country (United States) 2 of 2
Year (2019) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-14 IBA Molecular Imaging

Dulles, Vermont, United States

IBA Molecular is a global developer, manufacturer and distributor of radiopharmaceutical products and supporting services used in molecular imaging. IBA Molecular has engineered a strong and unique product portfolio and pipeline of diagnostic and therapeutic tracers aimed at advancing the development of the global movement towards personalized medicine and making molecular imaging/therapy a major discipline in healthcare. The company also provides educational, technical and marketing support to medical specialists worldwide to help better respond to patient needs.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-03 Modus Medical Devices

London, Ontario, Canada

Modus Medical Devices is specializes in phantoms, a manufactured product made to resemble human organ or tissue used to quantify the potential effects of a radiation dose on a patient. Modus Medical Devices was founded in 2000 and is based in London, Ontario.

Buy -
Mergr

Product

Company

Legal